Stocks that traded heavily or had substantial price changes on Monday: United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise
United Therapeutics: Q4 Earnings Snapshot
United Therapeutics: Q3 Earnings Snapshot
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’...
United Therapeutics: Q2 Earnings Snapshot
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street...
United Therapeutics (UTHR) delivered earnings and revenue surprises of 11.72% and 1.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
United Therapeutics: Q1 Earnings Snapshot
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2023. Total revenues in the first quarter of 2023 grew...